Plain-English translation of NCT06108492 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This is an early-stage (Phase I) clinical trial testing a new treatment called for bladder cancer. The medication is delivered directly into your bladder through instillation, which means it's placed in your bladder rather than taken by mouth or injection. Researchers want to learn if this treatment is safe, well-tolerated, and effective for people with intermediate or high-risk non-muscle invasive bladder cancer.
Current treatment options for non-muscle invasive bladder cancer have limitations, and doctors are seeking new ways to deliver medication directly to cancer cells in the bladder. This trial is testing whether this medication might offer a better treatment option for patients who have a higher risk of cancer recurrence or progression.
You likely qualify if…
You likely don't qualify if…
You will receive the medication through intravesical instillation, meaning a doctor will place it directly into your bladder. The study involves multiple clinic visits at one of several medical centers participating in this trial. You will be monitored for safety and tolerability, and researchers will take blood samples and monitor your bladder health to assess how well the treatment works.
AI-generated summary from trial data · Jun 10, 2026 · Not medical advice
China